<?xml version="1.0" encoding="UTF-8"?>
<p>We used routine data records of occupational disease from the German Statutory Accident Insurance in the Health and Welfare Services (BGW) to analyse treatment outcomes and associated costs arising from DAA treatment versus those of interferon-based therapy. This study was performed in line with the “Consensus German Reporting Standard for Secondary Data Analyses (STROSA)” [
 <xref rid="B16-ijerph-17-00440" ref-type="bibr">16</xref>] and with the “Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement” (
 <xref ref-type="app" rid="app1-ijerph-17-00440">Supplementary Table S1</xref>) [
 <xref rid="B17-ijerph-17-00440" ref-type="bibr">17</xref>]. 
</p>
